From: Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma
Cell line
CD33xCD33
EGFRxEGFR
EGFRxCD33
HER2xHER2
HER2xCD33
EGFRxHER2
SW1990
—
0.9
6.9
7.8
367.3
0.8
SW1990 EGFR-KO
38.3
557.5
229.5
SW1990 HER2-KO
0.2
6.4
8.2